Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
45.66
-0.32 (-0.70%)
At close: Jul 15, 2026, 4:00 PM EDT
45.58
-0.08 (-0.18%)
After-hours: Jul 15, 2026, 4:47 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $6.06 billion as of July 15, 2026. Its market cap has increased by 1,136.09% in one year.
Market Cap
6.06B
Enterprise Value
5.72B
1-Year Change
1,136.09%
Ranking
Category
Stock Price
$45.66
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $6.06B, an increase of 918.04%. That is a compound annual growth rate of 43.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 6.06B | 359.51% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 6.62B |
| Scholar Rock Holding | 6.47B |
| Xenon Pharmaceuticals | 6.45B |
| Cogent Biosciences | 6.42B |
| CG Oncology | 6.29B |
| Ligand Pharmaceuticals | 6.03B |
| Erasca | 5.95B |
| Belite Bio | 5.75B |